Brian P. Schmitt, MD, FACP
Schmitt BP. In HF, angiotensin–neprilysin inhibition reduced mortality and HF hospitalization compared with enalapril. Ann Intern Med. 2015;162:JC2. doi: 10.7326/ACPJC-2015-162-4-002
Download citation file:
Published: Ann Intern Med. 2015;162(4):JC2.
Cardiology, Coronary Risk Factors, Endocrine and Metabolism, Heart Failure, Hospital Medicine.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use